General Info

Our mission is to research, publish and distribute to doctors and the general public proven scientific information about integrative biological protocols for the prevention and treatment of cancer. Molecular biologist and cancer scientist, Angelo P. John, Sr. has had a lifelong passion for the study of biochemistry and a devotion to cancer research. It began when he was a child and continued through his college education and adult life. John founded the A. P. John Institute for Cancer Research in 1978. In previous years, John worked in cancer research with Dr. Stock during the doctor's tenure as Director at Memorial Sloan Kettering. John also operated his own research laboratory for more than 18 years. John has spent the past forty-five years researching, pioneering, and validating some of the most advanced clinically proven protocols for the treatment of cancer. In 1961, John published his first anti-cancer diet and nutritional book titled: Diaitis, Anti-Cancer Nutrients In Cancer Prevention & Cure. In it John outlines his theories about the prevention, causality, and treatment of cancer. And in 1985, John published his second book called: Amino Acids in the Prevention and Healing of AIDS. That book shares John's vast knowledge of immune system biochemistry, and it outlines dietary instructions for building and maintaining a healthy and effective immune system that thwarts the AIDS virus. The book contains recommendations for a high protein diet, mega dosages of vitamins and minerals, and intermittent dosages of radiation to the lymph nodes. John's theory that irradiating the lymph nodes successfully treats AIDS is undergoing clinical trials by Dr. Joseph M. McCune at the University of California, San Francisco. As far back as 1969 John developed his first two protocols for the treatment of cancer, one called Intra Tumor Therapy and the other, Ischemia Reperfusion Tumor Therapy. John's involvement in the Intra-Tumor Therapy began with a cancer study with biologist Robert Holman. The research proved that Intra-Tumor Therapy cured cancers in laboratory animals. The therapy involves injecting chemicals such as Hydrogen Peroxide and Acetic Acid directly into a tumor, which causes it to totally disappear. In 1995, the New England Journal of Medicine reported that Intra-Tumor Therapy is now the treatment of choice for liver cancer in Asia and Italy. John's patented Ischemia-Reperfusion Tumor Therapy involves inserting a catheter containing a balloon into an artery feeding a tumor. Every half-hour the balloon is either inflated or deflated. During that process of occlusion and reperfusion, the cancer cells undergo a series of chemical reactions that cause them to produce toxic free radicals and self-destruct. Researchers at Lund University in Sweden have proven that the process of occlusion and reperfusion does indeed cause cancer cells to die. Most notably, John developed an integrative biological protocol for the treatment of cancer. His protocol, Controlled Amino Acid Therapy (CAAT) is an amino acid and carbohydrate deprivation cancer therapy, which is administered to the patient for approximately six to nine months. It strategically and scientifically utilizes the chemical reactions and interactions between amino acids, foods and nutritional supplements to alter or impair the development of cancer cells. CAAT achieves this goal by interfering and blocking the five basic requirements of cell formation; structure, energy, blood vessels, growth hormones and functions. CAAT works synergistically with chemotherapy and/or radiation, and has also been proven effective alone.